These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36515446)

  • 1. The impact of COVID-19 on blood safety and availability in the Islamic Republic of Iran.
    Divkolaye N; Arabkhazaeli A; Hajibeigi B; Eshghi P
    East Mediterr Health J; 2022 Nov; 28(11):823-828. PubMed ID: 36515446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood supply sufficiency and safety management in Iran during the COVID-19 outbreak.
    Maghsudlu M; Eshghi P; Amini Kafi-Abad S; Sedaghat A; Ranjbaran H; Mohammadi S; Tabatabai SM
    Vox Sang; 2021 Feb; 116(2):175-180. PubMed ID: 32996588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the unseen effect of COVID 19 pandemic on blood transfusion services in a tertiary care centre.
    Kaur P; Bedi RK; Mittal K; Sood T
    Transfus Apher Sci; 2023 Apr; 62(2):103569. PubMed ID: 36088214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 related callback in blood donors; Outcomes in blood donors and patients.
    Balagholi S; Maghsudlu M; Amini-Kafiabad S; Nazemi AM; Sotoudeh Anvari M
    Transfus Apher Sci; 2021 Aug; 60(4):103129. PubMed ID: 33879420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
    Karimi G; Zadsar M; Pourfathollah AA
    Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pandemic blood donor demographics - Do changes impact blood safety?
    Vassallo RR; Bravo MD; Kamel H
    Transfusion; 2021 May; 61(5):1389-1393. PubMed ID: 33554333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood supply management in times of SARS-CoV-2 pandemic - challenges, strategies adopted, and the lessons learned from the experience of a hospital-based blood centre.
    Pandey HC; Coshic P; C S C; Arcot PJ; Kumar K
    Vox Sang; 2021 May; 116(5):497-503. PubMed ID: 33103772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and Hospitals.
    García-Erce JA; Romón-Alonso Í; Jericó C; Domingo-Morera JM; Arroyo-Rodríguez JL; Sola-Lapeña C; Bueno-Cabrera JL; Juárez-Vela R; Zalba-Marcos S; Abad-Motos A; Gea-Caballero V; Santolalla-Arnedo I; Quintana-Díaz M
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33801650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood donations and donors' profile in Lithuania: Trends for coming back after the COVID-19 outbreak.
    Kalibatas V; Kalibatienė L; Imashpayev D
    PLoS One; 2024; 19(1):e0297580. PubMed ID: 38271329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of blood donors' characteristics and deferrals related to COVID-19 in Iran.
    Rafiee MH; Kafiabad SA; Maghsudlu M
    Transfus Apher Sci; 2021 Apr; 60(2):103049. PubMed ID: 33468406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H
    Transfus Med; 2009 Aug; 19(4):189-94. PubMed ID: 19708860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A
    PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the COVID-19 pandemic on blood donations and transfusions in Nigeria - A multi-facility study of 34 tertiary hospitals.
    Oreh A; Bozegha T; Ihimekpen A; Biyama F; Irechukwu C; Aliu S; Oshiame D; Nnabuihe A; Ndanitsa A; Nnachi O; Ogbenna A; Abubakar S; Olupitan F; Akinkunmi A; Ogunlade C; Abayomi T; Omokaro U; Sylvester C; Igiebor U; Wokoma B; Ebophni S; Adewuyi B; Dachi R; Muhammad H; Abubakar M; Mgbang J; Chineke A; Ogbuabor O; Fakai G; Hashim B; Adeluwoye N; Olanrewaju D; Agahiu E; Etim E; Alabi S; Akinbola I; Anibueze C; Awogbami O; Edowhorhu G; Adekoya-Benson T; Bello S; Ojuade Y; Amedu O
    Niger J Clin Pract; 2022 Jun; 25(6):786-793. PubMed ID: 35708419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivation, blood donor satisfaction and intention to return during the COVID-19 pandemic.
    Weidmann C; Derstroff M; Klüter H; Oesterer M; Müller-Steinhardt M
    Vox Sang; 2022 Apr; 117(4):488-494. PubMed ID: 34725833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in blood donations, blood donors' knowledge, practices and expectations during the COVID-19 pandemic in Cameroon.
    Tagny CT; Lendem I; Ngo Sack F; Ngo Balogog P; Ninmou C; Dongmo A; Ndoumba A; Tante E; Ateba N; Ndemanou M; Tapko JB; Mbanya D
    Vox Sang; 2021 Jul; 116(6):637-644. PubMed ID: 33314185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic.
    Al-Riyami AZ; Burnouf T; Wood EM; Devine DV; Oreh A; Apelseth TO; Goel R; Bloch EM; van Den Berg K; Getshen M; Louw V; Ang AL; Lee CK; Rahimi-Levene N; Stramer SL; Vassallo R; Schulze TJ; Patidar GK; Pandey HC; Dubey R; Badawi M; Hindawi S; Meshi A; Matsushita T; Sorrentino E; Grubovic Rastvorceva RM; Bazin R; Vermeulen M; Nahirniak S; Tsang HC; Vrielink H; Triyono T; Addas-Carvalho M; Hećimović A; Torres OW; Mutindu SM; Bengtsson J; Dominguez D; Sayedahmed A; Hanisa Musa R; Gautam B; Herczenik E; So-Osman C;
    Vox Sang; 2022 Jun; 117(6):822-830. PubMed ID: 35262978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation.
    Ogar CO; Okoroiwu HU; Obeagu EI; Etura JE; Abunimye DA
    Transfus Clin Biol; 2021 Feb; 28(1):68-72. PubMed ID: 33080420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four decades of National Blood Service in Iran: outreach, prospect and challenges.
    Pourfathollah AA; Hosseini Divkolaye NS; Seighali F
    Transfus Med; 2015 Jun; 25(3):138-43. PubMed ID: 26040645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.